Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morales, P.
Right arrow Articles by Pizarro, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morales, P.
Right arrow Articles by Pizarro, E.
Agricola
Right arrow Articles by Morales, P.
Right arrow Articles by Pizarro, E.
Biology of Reproduction 67, 1360-1365 (2002)
© 2002 Society for the Study of Reproduction, Inc.

Inhibition of In Vivo and In Vitro Fertilization in Rodents by Gonadotropin-Releasing Hormone Antagonists1

Patricio Morales2,a, Consuelo Pastena, and Eduardo Pizarroa

a Unit of Reproductive Biology, Faculty of Health Sciences, University of Antofagasta, Antofagasta, Chile

We have examined the effect of two GnRH antagonists, Ac-D-Nal1-Cl-D-Phe2-3-Pyr-D-Ala3-Arg5-D-Glu(AA)6-GnRH (Nal-Glu) and Ac3,4-dehydro-Pro1,-p-fluoro-D-Phe2,D-Trp3,6-GnRH (4pF), on in vivo and in vitro fertilization in rodents. Female rats were treated in the afternoon of proestrus with 2 µl of Nal-Glu or 4pF (0.5 and 5 mM) injected directly into one oviductal horn (experimental); saline was injected into the contralateral horn (control). Females were then mated and the oviducts were perfused for egg and sperm recovery. The results indicate that both antagonists inhibited in vivo fertilization. Thus, the percentage of fertilized eggs in control oviducts ranged from 92% ± 5% to 100% ± 0%, whereas in treated oviducts, fertilization ranged from 25% ± 6% to 73% ± 5%. GnRH antagonists did not interfere with the process of ovulation, sperm migration to the site of fertilization, or early embryo development. In additional experiments with mice, GnRH antagonists inhibited in vitro fertilization. One fertilization event that was specifically inhibited by GnRH antagonists was the process of sperm binding to the zona pellucida. This step was precisely monitored using the hemizona assay. GnRH antagonists did not affect sperm movement or acrosomal status. These observations indicated that local treatment with GnRH antagonists inhibit in vivo fertilization and give additional support to the idea that endogenous GnRH may play an important role during fertilization by increasing the efficiency of sperm-zona binding.

1 This work was financed by Fondecyt 197 1243. The investigation received financial support through project A05139 from the Special Programme of Research, Development, and Research Training in Human Reproduction sponsored by the United Nations Development Programme, United Nations Population Fund, World Health Organization, and the World Bank. C.P. and E.P. are recipients of the PROGRESAR fellowship.

2 Correspondence: Patricio Morales, Unit of Reproductive Biology, Faculty of Health Sciences, University of Antofagasta, P.O. Box 170, Antofagasta, Chile. FAX: 5655 637 802; pmorales{at}uantof.cl







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for the Study of Reproduction.